ProteinQure Series A

ProteinQure is a clinical-stage biotechnology company that leverages its proprietary computational platform, ProteinStudio™, to design novel peptide therapeutics. Their platform integrates machine learning, structural biology, and atomic-level simulations to create peptide-drug conjugates for diseases like cancer. They are advancing a pipeline of internal and partnered drug discovery projects, with a focus on precision medicine and targeted drug delivery.